PTA球囊导管市场分析报告| 2031 年规模、趋势和增长展望

  • Report Code : TIPRE00019594
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

PTA Balloon Catheter Market Analysis Report | Size, Trends & Growth Outlook 2031

Buy Now

[研究报告]PTA球囊导管市场规模预计将从2022年的21.75亿美元增长到2030年的41.3854亿美元;预计 2022 年至 2030 年市场复合年增长率为 8.5%。

分析师观点

PTA 球囊导管市场分析涉及市场驱动因素、限制因素和市场机会。动脉粥样硬化性疾病及其由此产生的并发症等心血管疾病 (CVD) 数量的增加,全球范围内的心肌梗塞、中风、肾衰竭和肢体缺血等疾病导致血管成形术等心脏手术的增加。此外,由于其相对于传统方法的优势,对心血管疾病微创手术的需求也在增长。这些因素正在推动 2022 年至 2030 年 PTA 球囊导管市场的增长。然而,产品召回预计将阻碍预测期内市场的增长。此外,推出先进的创新技术来改善药物涂层球囊 (DCB) 的可视化和集成,正在成为 2023 年至 2030 年 PTA 球囊导管市场的趋势。

市场洞察

PTA(经皮腔内血管成形术)球囊导管是一种医疗器械,可改善患有血管问题的患者外周动脉的血流。 PTA球囊导管是一种微创技术,用于治疗外周动脉疾病、狭窄和血栓形成等血管疾病。对于患有血管问题的个人来说,这种新颖的小工具是一种安全、有效且可靠的治疗选择。

市场驱动因素

动脉粥样硬化疾病数量的增加和微创心脏手术需求的增加推动市场增长

动脉粥样硬化,也称为冠状动脉疾病(CAD)是最常见的心血管疾病(CVD)。其特点是胆固醇积聚和主动脉炎症,最终可能导致心肌梗塞 (MI) 和中风等临床问题。吸烟、高血压、胆固醇水平升高和糖尿病会加速动脉硬化过程。 50岁以上的人更容易出现动脉硬化或有冠心病家族史。根据 StatPearls 2023 年 8 月发表的一篇文章,动脉粥样硬化是一种动脉慢性炎症性疾病,约占西方社会所有死亡人数的 50%,导致约 37 万人死亡。在美国,每年有超过 610,000 人死于心脏病,占死亡人数的四分之一。中风是美国第五大死亡原因,也是导致严重长期残疾的首要原因。缺血性中风是最常见的中风类型,由 ASCVD 引起。

美国每年约有 795,000 人患有中风,导致约 140,323 人死亡。血管成形术是一种微创手术,使用 PTA 球囊导管来打开由潜在动脉粥样硬化引起的阻塞或狭窄的冠状动脉。血管成形术对 90% 以上的患者打开冠状动脉效果良好,因为它迫使动脉粥样硬化斑块抵住动脉壁,恢复管腔直径。根据StatPearls 2023年2月发表的一篇文章,经皮腔内冠状动脉成形术(PTCA)的发病率和死亡率较低,恢复时间较短,成本较低。它的成功率高达 90%,可有效消除动脉狭窄。

此外,一项研究“用于瘘管和移植物维持手术的标准 PTA 球囊与新型 PTA 球囊的程序比较” Chameleon PTA 球囊导管,”该研究于 2021 年 12 月发表,研究对象包括 68 名连续患有高血压、冠状动脉疾病和糖尿病的患者,这些患者的高血压、冠状动脉疾病和糖尿病发病率与全国平均水平相似。研究结论是,使用带有集成注射口的 PTA 球囊有可能显着减少造影剂剂量、透视时间和手术时间。

因此,PTA 导管的应用用于血管成形术的球囊和动脉粥样硬化疾病病例的增加正在推动 PTA 球囊导管市场的增长。

此外,由于其微创手术相对于开放手术的优势,人们对微创手术的偏好也在增加。成本更低、创伤最小、恢复更快、并发症风险低。印度和巴西等新兴市场心血管疾病的患病率不断上升,以及这些国家对微创手术的承受能力和偏好不断提高,正在推动行业增长。

战略洞察

市场趋势

整合药物涂层球囊 (DCB) 与 PTA 球囊导管的结合

药物涂层球囊 (DCB) 作为一种非支架治疗方法正变得越来越流行动脉粥样硬化病变。 DCB 被认为是介入心脏病学的重要工具,通过单次长时间的涂层球囊血管成形术充气,将抗增殖药物(例如紫杉醇或西罗莫司)直接输送到局部动脉组织。从理论上讲,这种方法可以降低对装置组件的晚期炎症反应的风险,同时还促进积极的重塑。与支架置入术相比,它们具有更好的局部药物吸收和潜在的更少血管变形的优点。它们可能对无法用支架治疗的病变(例如支架内再狭窄、小血管和复杂的隆凸分叉病变)有用。许多主要参与者都致力于推出用于治疗动脉粥样硬化疾病的血管成形术的 DCB。

参与者的一些技术进步以下提及PTA导管球囊装置中的应用:

  • 2023年10月,波士顿科学公司宣布其AGENT药物涂层球囊的关键AGENT IDE临床试验取得积极结果(DCB)治疗冠状动脉支架内再狭窄(ISR)。该试验得出了令人鼓舞的 12 个月主要终点结果,并且在美国尚属首次。该试验评估了使用 DCB 治疗冠状动脉支架内再狭窄 (ISR) 的安全性和有效性,这些主要终点结果已在心血管研究基金会的年度科学研讨会上公布。
  • 2023 年 6 月,医疗保健行业医疗器械和体外诊断技术的顶级供应商 Surmodics, Inc. 的 SurVeil 药物涂层球囊 (DCB) 获得美国食品和药物管理局 (FDA) 的批准。
  • 2021年7月,美敦力在欧洲推出了其最新一代药物涂层球囊导管Prevail药物涂层球囊(DCB)导管,用于治疗冠状动脉疾病。 Prevail DCB 利用紫杉醇治疗新发病变、小血管疾病和支架内再狭窄 (ISR)。

因此,这些技术进步正在推动 PTA 的发展球囊导管市场。

报告细分和范围

“全球 PTA 球囊导管”市场”根据材料类型、应用和最终用户进行细分。根据材料类型,PTA 球囊导管市场分为聚氨酯、尼龙等。根据应用,PTA 球囊导管市场分为冠状动脉疾病和外周动脉疾病。根据最终用户,市场分为医院、门诊手术中心等。 PTA球囊导管市场根据地理位置分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度) 、韩国和亚太地区其他地区)、中东和美国非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

基于材料类型的见解

根据材料类型,PTA 球囊导管市场分为聚氨酯、尼龙等。 2022 年,尼龙细分市场占据最大市场份额;预计 2022 年和 2030 年复合年增长率最高。

基于应用程序的见解

<根据应用,PTA球囊导管市场分为冠状动脉疾病和外周动脉疾病。由于老年人口动脉粥样硬化的增加、吸烟和人们久坐的生活方式,外周动脉疾病细分市场在 2022 年占据最大的市场份额。外周动脉疾病 (PAD) 是由动脉中脂肪斑块积聚引起的,这种情况称为动脉粥样硬化。这是将血液从心脏输送到腿部的静脉变窄或阻塞。据美国疾病控制与预防中心 (CDC) 统计,2021 年,美国 40 岁以上约有 650 万人患有 PAD。

基于最终用户的洞察

就最终用户而言,PTA球囊导管市场分为医院、门诊手术中心等。 2022 年,医院细分市场占据最大市场份额,由于心血管手术数量不断增加,预计门诊手术中心细分市场在 2022 年至 2030 年复合年增长率最高。慢性病患病率的上升、老年人口的增加以及医院数量的增加主要促进了医院领域球囊导管市场的增长。在老年人群中,住院治疗的需求几乎是中年成年人需求的两倍;大约 17% 的 65 岁及以上美国人每年至少住院一次,而只有 8% 的 45 岁至 64 岁成年人需要住院治疗。因此,在预测期内,住院患者数量的增加可能会促进医院市场的增长。

PTA 球囊导管市场按应用程序 – 2022年和2030年

区域分析

北美 PTA 球囊导管市场分为美国、加拿大和墨西哥。市场增长归因于 CAD 和 PAD 数量的增加以及技术进步的不断进步。美国已成为北美市场增长的主要贡献者。据美国心脏协会2021年发布的统计,美国每年进行超过50万例经皮冠状动脉介入治疗,其中包括经皮腔内冠状动脉介入治疗。

此外,几家主要制造商的存在、技术先进设备的引进以及有利的报销政策正在推动该地区的增长。

此外,预计亚太地区以全球 PTA 球囊导管市场最高复合年增长率增长。

该报告介绍了全球 PTA 球囊导管市场的领先企业。其中包括 Medtronic、Tuermo Corporation、Cardinal Health、Boston Scientific、Becton Dickinson and Co., Corporation、Natec Medical、Cook Medical、Biotronik、Surmodics, Inc. 和 Andratec。这些参与者专注于扩大市场份额并使其多元化,并获取新的客户群,挖掘 PTA 球囊导管市场的现有商机。

近期发展的一些示例

  • 2023年6月,库克医疗在美国推出Advance Serenity亲水性经皮腔内血管成形术(PTA)球囊导管,加拿大。该设备由 Surmodics 制造,由 Cook Medical 分销。 Advance Serenity 导管专为治疗外周动脉疾病(包括膝下疾病)而设计。该导管产品组合有两种不同的导丝平台,直径分别为 0.014 英寸和 0.018 英寸,并将提供各种球囊长度和直径。
  • 2023 年 3 月,BrosMed 推出了一系列产品。 s Tiche 0.035”高压PTA球囊扩张导管获得欧洲医疗器械法规(MDR)认证。它是一种高度可输送的 0.035 英寸经皮腔内血管成形术 (PTA) 导管,专为各种外周血管成形术而设计。该认证标志着BrosMed的首张MDR证书。该公司已获得美国食品和药物管理局的许可。其 Tiche 0.035" PTA 球囊扩张导管已于 2022 年 7 月通过美国药物管理局的 510(k) 流程。该产品计划首先在美国上市。
  • 2021 年 3 月,美敦力 (Medtronic)在德国、意大利、葡萄牙、南非、西班牙和土耳其推出了 Chameleon 经皮腔内血管成形术 (PTA) 球囊导管。该设备设计用于天然和合成动静脉透析瘘,以及股骨、髂骨和肾脏导管具有位于球囊附近的集成注射端口,可以输注诊断或治疗液体。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Medtronic plc
2. Terumo Corporation
3. Cardinal Health
4. Boston Scientific Corporation
5. Natec Medical and Surmodics, Inc
6. Cook Medical
7. Biotronik
8. Andratec
9. Stron Medical.
10. Freudenberg Medical

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..